SLRX
Salarius Pharmaceuticals Inc
-8.52%
$2.23 - $2.04
Feb 8th 2023 - Mar 22nd 2023
Jan, 20, 2023
$SLRX Enough cash flow for got damn 7!
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K flo... See more
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Jan, 30, 2023
Translate the data on this (today's sec releas... See more
Jan, 4, 2023
Approved, best in class drug with a huge market an... See more
Jan, 20, 2023
$SLRX Enough cash flow for got damn 7!
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K float 500%+ Cost to Borrow $3M MC w/ $14M in cash Recent analyst targets of $15.00+ Excellent technical setup Also watching: $WISA $SLRX $GNUS
Jan, 20, 2023
$SLRX I like all the excitement on this board, and the $7.38 cash per share
Jan, 19, 2023
News, cash, high volume, no more halts as it's AH's. ;) 🔥
Jan, 18, 2023
cash share is 7 🚀
Mar, 14, 2023
$HKD best thing I did was park some cash here.
Mar, 12, 2023
Doubled in size and reduced cash burn with no risk of dilution.
Mar, 10, 2023
Some sort of individual monster/mysterious ticker with cash flow positive and good PER.
Mar, 8, 2023
Gross profit margins of 98 percent, no debt, major cash reserves.
Mar, 8, 2023
Gross profit margins of 98 percent, no debt, major cash reserves.
Mar, 8, 2023
They have a a massive amount of cash and no debt along with 97 pct profit margin.
Feb, 26, 2023
1 month of steady increase, not random pump 💩 $LMFA 💰 10m cash 💰70m assets ✅14m market cap 🚀100%+ gains from current levels / most likely 250%+ 📆 NASDAQ COMPLIANCE NEXT WEEK
Feb, 23, 2023
$HKD amazing growth, no debt, massive amount of cash, 98% profit margin.
Feb, 23, 2023
$HKD it's pretty simple, no debt, crazy amount of cash, huge increase first six months revenue and way undervalued.
Feb, 23, 2023
No debt, ridiculous amount of cash and 98 percent profit margin.
Jan, 30, 2023
Translate the data on this (today's sec release) Seems VERY positive and with a cash run into 2024 on worst case basis.
Jan, 4, 2023
Approved, best in class drug with a huge market and a nice pile of cash, it checks every box.
Dec, 29, 2022
Amazing positive news from the TGTX 20221229 conference call, FDA approved, 🚨🔥🚨 Ublituximab Briumvi: 1) No need for additional funds, no offering, no need for capital raise, because 220 million in cash reserves expected to last until mid 2024.
Dec, 29, 2022
$TGTX Plenty of cash on hand and commercialization up and coming.